2006 Annual Meeting | Genetics in Neurology
| 09:00 AM - 09:45 AM | Phakomatoses Stefan M. Pulst, MD, FAAN | |
| 09:45 AM - 10:30 AM | DNA Repeat Mutations Henry L. Paulson, MD, PhD, FAAN | |
| 10:30 AM - 10:45 AM | Break | |
| 10:45 AM - 11:30 AM | Movement Disorders Christine Klein, MD | |
| 11:30 AM - 12:15 PM | Inherited Myopathies Kevin M. Flanigan, MD, FAAN | |
| 12:15 PM - 01:30 PM | Lunch | |
| 01:30 PM - 02:15 PM | Inherited Epilepsies Massimo Pandolfo, MD, FAAN | |
| 02:15 PM - 03:00 PM | Autism Sarah J. Spence, MD, PhD | |
| 03:00 PM - 03:15 PM | Break | |
| 03:15 PM - 04:00 PM | Genetics of Dementia Thomas D. Bird, MD, FAAN | |
| 04:00 PM - 04:45 PM | Mitochondrial Disease Salvatore DiMauro, MD | |
| 04:45 PM - 05:00 PM | Questions and Answers | 
| Salvatore DiMauro, MD | No disclosure on file | 
| Stefan M. Pulst, MD, FAAN | Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care. | 
| Christine Klein, MD | Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Centogene and Retromer Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Mov Disord, Ann Neurol, Science Adv. The institution of Dr. Klein has received research support from Centogene. Dr. Klein has received publishing royalties from a publication relating to health care. | 
| Henry L. Paulson, MD, PhD, FAAN | Dr. Paulson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exicure. The institution of Dr. Paulson has received research support from National Institutes of Health. Dr. Paulson has a non-compensated relationship as a Member, Nominating committee with American Neurological Association that is relevant to AAN interests or activities. | 
| Kevin M. Flanigan, MD, FAAN | Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Armatus. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne. The institution of Dr. Flanigan has received research support from Ultragenyx . The institution of Dr. Flanigan has received research support from Solid Biosciences. The institution of Dr. Flanigan has received research support from Dyne Therapeutics. The institution of Dr. Flanigan has received research support from Avidity. | 
| Massimo Pandolfo, MD, FAAN | Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Bio. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities. | 
| Thomas D. Bird, MD, FAAN | Dr. Bird has nothing to disclose. | 
| Sarah J. Spence, MD, PhD | Dr. Spence has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for dup15qalliance. The institution of Dr. Spence has received research support from Hoffman La Roche. The institution of Dr. Spence has received research support from NIH. |